Global Lung Cancer Screening Software Market - Industry Trends and Forecast to 2029
- Published Date: 2022-12-22
- Report ID: 143149
- Pages: 225
-
Format:
Short Description
Global Lung Cancer Screening Software Market, By Product (Lung Cancer Screening Radiology Solution, Lung Cancer Screening Patient Management Software, Nodule Management Software, Data Collection and Reporting, Patient Coordination and Workflow, Lung Nodule Computer Aided Detection, Pathology and Cancer Staging, Statistical Audit Reporting, Screening PACS, Practice Management, and Audit Log Tracking), Mode of Delivery (Web Based Solutions, On-Premise Solutions, and Cloud Based Solutions), Type (Computer Assisted Screening and Traditional Screening), Application (Small Cell Lung Cancer and Non-Small Cell Lung Cancer), Platform (Standalone and Integrated), Purchase Mode (Individual and Institutional), End User (Hospitals, Oncology Centers, Ambulatory Surgical Centers, and Others), Distribution Channel (Direct Tender and Third Party Distributors), Region (North America, Europe, Asia-Pacific, South America, and Middle East and Africa) Industry Trends and Forecast to 2029
Market Definition
Lung cancer screening is identifying stages of lung cancer using different technologies and software. Lung cancer screening using CT is the most recommended technique of screening lung cancer. Rising use of this technique is expected to accelerate the need for advanced software for lung cancer screening. These software help to manage patients participation in lung screening programs and provide an efficient way for healthcare professionals to collect, curate, and transfer data to clinicians and patients. In addition, these software enable in identifying patients at risk and automates flow of data with integrated electronic health records.
Market Segmentation
Global lung cancer screening software market is divided into seven notable segments which are based on product, mode of delivery, type, application, platform, purchase mode, end user, and distribution channel.
On the basis of product, the market is segmented into lung cancer screening radiology solution, lung cancer screening patient management software, nodule management software, data collection and reporting, patient coordination and workflow, lung nodule computer aided detection, pathology and cancer staging, statistical audit reporting, screening PACS, practice management, and audit log tracking
On the basis of mode of delivery, the market is segmented into cloud based solutions, on-premise solutions, and web based solutions
On the basis of type, the market is segmented into computer-assisted screening and traditional screening
On the basis of application, the market is segmented into Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC)
On the basis of platform, the market is segmented into standalone and integrated
On the basis of purchase mode, the market is segmented into individual and institutional
On the basis of end user, the market is segmented into hospitals, oncology centers, ambulatory surgical centers, and others
On the basis of distribution channel, the market is segmented into direct tender and third party distributors
Market Players
Some of the major players operating in the Global lung cancer screening software market are:
Koninklijke Philiphs N.V
Siemens Healthcare GmbH
Nuance Communication, Inc.
General Electric Company
Oncocyte Corporation
Aidence.com
AstraZeneca
Canon Medical Informatics, Inc.
Coreline Soft, Co., Ltd.
Eon
Epic Systems Corporation
F. Hoffmann-La Roche Ltd
FUJIFILM Holdings Corporation
Genesystem
HealthMyne
Lungview
MagView
Median Technologies
Medtronic
MeVis Medical Solutions AG
MyCareWare Inc.
Optellum Ltd
PenRad Technologies Inc.
REVEALDX
Thynk Health
Volpara Health Limited
TABLE OF CONTENTS
1 INTRODUCTION 62
1.1 OBJECTIVES OF THE STUDY 62
1.2 MARKET DEFINITION 62
1.3 OVERVIEW OF GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET 62
1.4 LIMITATION 64
1.5 MARKETS COVERED 65
2 MARKET SEGMENTATION 68
2.1 MARKETS COVERED 68
2.2 GEOGRAPHICAL SCOPE 69
2.3 YEARS CONSIDERED FOR THE STUDY 70
2.4 CURRENCY AND PRICING 70
2.5 DBMR TRIPOD DATA VALIDATION MODEL 71
2.6 MULTIVARIATE MODELLING 74
2.7 PRODUCT LIFELINE CURVE 74
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 75
2.9 DBMR MARKET POSITION GRID 76
2.10 VENDOR SHARE ANALYSIS 78
2.11 SECONDARY SOURCES 79
2.12 ASSUMPTIONS 79
3 EXECUTIVE SUMMARY 80
4 PREMIUM INSIGHTS 84
5 REGULATIONS & REIMBURSEMENT 86
6 MARKET OVERVIEW 87
6.1 DRIVERS 89
6.1.1 INCREASE IN PREVALENCE OF LUNG CANCER CASES GLOBALLY 89
6.1.2 INCREASE IN AWARENESS REGARDING THE BENEFITS OF EARLY DIAGNOSIS AND FREQUENT SCREENING 89
6.1.3 GOVERNMENT INITIATIVES WERE UNDERTAKEN TO IMPLEMENT SCREENING PROGRAMS FOR VARIOUS DISEASES 90
6.1.4 GROWING NUMBER OF SCREENING PROGRAMS ACROSS THE GLOBE 90
6.1.5 TECHNOLOGICAL ADVANCEMENTS IN THE FIELD OF HEALTHCARE 91
6.2 RESTRAINTS 92
6.2.1 ISSUES RELATED TO THE AVAILABILITY OF SOFTWARE 92
6.2.2 SCARCITY OF TECHNICALLY KNOWLEDGEABLE PROFESSIONALS FOR CANCER DIAGNOSIS 92
6.2.3 LACK OF FUNDING AND OTHER RESOURCES FROM VARIOUS REGIONS FOR CANCER AND ASSOCIATED DISORDERS 92
6.3 OPPORTUNITIES 93
6.3.1 RISING COLLABORATIONS, MERGERS & ACQUISITIONS AMONG THE MARKET PLAYERS 93
6.3.2 INCREASING INVESTMENTS IN HEALTHCARE SEGMENTS 94
6.3.3 MULTIPLE BENEFITS ASSOCIATED WITH LUNG CANCER SCREENING SOFTWARE 94
6.4 CHALLENGES 95
6.4.1 HIGH COST OF SCREENING SOFTWARE AND RELATED SERVICES 95
6.4.2 INCREASING CHALLENGES RELATED TO THE DEVELOPMENT OF LUNG CANCER SCREENING SOFTWARE 95
6.4.3 INCREASING COMPETITION IN THE MARKET 96
7 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET, BY MODE OF DELIVERY 97
7.1 OVERVIEW 98
7.2 CLOUD BASED SOLUTIONS 99
7.3 ON-PREMISE SOLUTIONS 100
7.4 WEB BASED SOLUTIONS 100
8 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT 102
8.1 OVERVIEW 103
8.2 LUNG CANCER SCREENING RADIOLOGY SOLUTION 105
8.2.1 ON-PREMISE SOLUTIONS 105
8.2.2 WEB BASED SOLUTIONS 106
8.2.3 CLOUD BASED SOLUTIONS 106
8.3 LUNG CANCER SCREENING PATIENT MANAGEMENT SOFTWARE 106
8.3.1 CLOUD BASED SOLUTIONS 107
8.3.2 ON-PREMISE SOLUTIONS 107
8.3.3 WEB BASED SOLUTIONS 107
8.4 NODULE MANAGEMENT SOFTWARE 107
8.4.1 CLOUD BASED SOLUTIONS 108
8.4.2 ON-PREMISE SOLUTIONS 108
8.4.3 WEB BASED SOLUTIONS 108
8.5 DATA COLLECTION AND REPORTING 109
8.5.1 CLOUD BASED SOLUTIONS 110
8.5.2 WEB BASED SOLUTIONS 110
8.5.3 ON-PREMISE SOLUTIONS 110
8.6 PATIENT COORDINATION AND WORKFLOW 110
8.6.1 CLOUD BASED SOLUTIONS 111
8.6.2 ON-PREMISE SOLUTIONS 111
8.6.3 WEB BASED SOLUTIONS 111
8.7 LUNG NODULE COMPUTER AIDED DETECTION 111
8.7.1 ON-PREMISE SOLUTIONS 112
8.7.2 CLOUD BASED SOLUTIONS 112
8.7.3 WEB BASED SOLUTIONS 112
8.8 PATHOLOGY AND CANCER STAGING 113
8.8.1 CLOUD BASED SOLUTIONS 114
8.8.2 ON-PREMISE SOLUTIONS 114
8.8.3 WEB BASED SOLUTIONS 114
8.9 STATISTICAL AUDIT REPORTING 114
8.9.1 CLOUD BASED SOLUTIONS 115
8.9.2 ON-PREMISE SOLUTIONS 115
8.9.3 WEB BASED SOLUTIONS 115
8.10 SCREENING PACS 115
8.10.1 CLOUD BASED SOLUTIONS 116
8.10.2 ON-PREMISE SOLUTIONS 116
8.10.3 WEB BASED SOLUTIONS 116
8.11 PRACTICE MANAGEMENT 116
8.11.1 CLOUD BASED SOLUTIONS 117
8.11.2 ON-PREMISE SOLUTIONS 118
8.11.3 WEB BASED SOLUTIONS 118
8.12 AUDIT LOG TRACKING 118
8.12.1 CLOUD BASED SOLUTIONS 119
8.12.2 ON-PREMISE SOLUTIONS 119
8.12.3 WEB BASED SOLUTIONS 119
9 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE 120
9.1 OVERVIEW 121
9.2 COMPUTER-ASSISTED SCREENING 122
9.2.1 CLOUD BASED SOLUTIONS 123
9.2.2 ON-PREMISE SOLUTIONS 123
9.2.3 WEB BASED SOLUTIONS 123
9.3 TRADITIONAL SCREENING 123
9.3.1 CLOUD BASED SOLUTIONS 124
9.3.2 ON-PREMISE SOLUTIONS 124
9.3.3 WEB BASED SOLUTIONS 124
10 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION 125
10.1 OVERVIEW 126
10.2 NON-SMALL CELL LUNG CANCER (NSCLC) 127
10.2.1 CLOUD BASED SOLUTIONS 128
10.2.2 ON-PREMISE SOLUTIONS 128
10.2.3 WEB BASED SOLUTIONS 128
10.3 SMALL CELL LUNG CANCER (SCLC) 128
10.3.1 CLOUD BASED SOLUTIONS 129
10.3.2 ON-PREMISE SOLUTIONS 129
10.3.3 WEB BASED SOLUTIONS 129
11 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM 130
11.1 OVERVIEW 131
11.2 STANDALONE 132
11.2.1 CLOUD BASED SOLUTIONS 133
11.2.2 ON-PREMISE SOLUTIONS 133
11.2.3 WEB BASED SOLUTIONS 133
11.3 INTEGRATED 133
11.3.1 CLOUD BASED SOLUTIONS 134
11.3.2 ON-PREMISE SOLUTIONS 134
11.3.3 WEB BASED SOLUTIONS 134
12 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET, BY PURCHASE MODE 135
12.1 OVERVIEW 136
12.2 INSTITUTIONAL 137
12.3 INDIVIDUAL 138
13 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET, BY END USER 139
13.1 OVERVIEW 140
13.2 ONCOLOGY CENTERS 141
13.3 HOSPITALS 142
13.4 AMBULATORY SURGICAL CENTERS 142
13.5 OTHERS 143
14 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET, BY DISTRIBUTION CHANNEL 144
14.1 OVERVIEW 145
14.2 DIRECT TENDERS 146
14.3 THIRD PARTY DISTRIBUTOR 147
15 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION 148
15.1 OVERVIEW 149
15.2 NORTH AMERICA 155
15.2.1 U.S. 166
15.2.2 CANADA 173
15.2.3 MEXICO 180
15.3 EUROPE 187
15.3.1 GERMANY 199
15.3.2 FRANCE 206
15.3.3 U.K. 213
15.3.4 ITALY 220
15.3.5 SPAIN 227
15.3.6 NETHERLANDS 234
15.3.7 RUSSIA 241
15.3.8 SWITZERLAND 248
15.3.9 BELGIUM 255
15.3.10 TURKEY 262
15.3.11 REST OF EUROPE 269
15.4 ASIA-PACIFIC 270
15.4.1 JAPAN 282
15.4.2 CHINA 289
15.4.3 AUSTRALIA 296
15.4.4 SOUTH KOREA 304
15.4.5 INDIA 312
15.4.6 SINGAPORE 320
15.4.7 THAILAND 327
15.4.8 MALAYSIA 334
15.4.9 INDONESIA 341
15.4.10 PHILIPPINES 348
15.4.11 REST OF ASIA-PACIFIC 355
15.5 SOUTH AMERICA 356
15.5.1 BRAZIL 367
15.5.2 ARGENTINA 374
15.5.3 REST OF SOUTH AMERICA 381
15.6 MIDDLE EAST & AFRICA 382
15.6.1 SOUTH AFRICA 394
15.6.2 SOUTH AFRICA 401
15.6.3 U.A.E 408
15.6.4 ISRAEL 415
15.6.5 EGYPT 422
15.6.6 REST OF MIDDLE EAST AND AFRICA 429
16 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET: COMPANY LANDSCAPE 430
16.1 COMPANY SHARE ANALYSIS: GLOBAL 430
16.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 431
16.3 COMPANY SHARE ANALYSIS: EUROPE 432
16.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 433
17 SWOT ANALYSIS 434
18 COMPANY PROFILE 435
18.1 KONINKLIJKE PHILIPS N.V 435
18.1.1 COMPANY SNAPSHOT 435
18.1.2 REVENUE ANALYSIS 435
18.1.3 COMPANY SHARE ANALYSIS 436
18.1.4 PRODUCT PORTFOLIO 436
18.1.5 RECENT DEVELOPMENTS 436
18.2 SIEMENS HEALTHCARE GMBH 438
18.2.1 COMPANY SNAPSHOT 438
18.2.2 REVENUE ANALYSIS 438
18.2.3 COMPANY SHARE ANALYSIS 439
18.2.4 PRODUCT PORTFOLIO 439
18.2.5 RECENT DEVELOPMENTS 439
18.3 NUANCE COMMUNICATIONS, INC. 441
18.3.1 COMPANY SNAPSHOT 441
18.3.2 REVENUE ANALYSIS 441
18.3.3 COMPANY SHARE ANALYSIS 442
18.3.4 PRODUCT PORTFOLIO 442
18.3.5 RECENT DEVELOPMENTS 442
18.4 GENRAL ELECTRIC (GE HEALTHCARE) 444
18.4.1 COMPANY SNAPSHOT 444
18.4.2 COMPANY SHARE ANALYSIS 444
18.4.3 PRODUCT PORTFOLIO 445
18.4.4 RECENT DEVELOPMENTS 445
18.5 ONCOCYTE CORPORATION 446
18.5.1 COMPANY SNAPSHOT 446
18.5.2 REVENUE ANALYSIS 446
18.5.3 COMPANY SHARE ANALYSIS 447
18.5.4 PRODUCT PORTFOLIO 447
18.5.5 RECENT DEVELOPMENT 447
18.6 AIDENCE.COM 448
18.6.1 COMPANY SNAPSHOT 448
18.6.3 PRODUCT PORTFOLIO 448
18.6.4 RECENT DEVELOPMENT 448
18.7 ASTRAZENECA 449
18.7.1 COMPANY SNAPSHOT 449
18.7.2 REVENUE ANALYSIS 449
18.7.3 PRODUCT PORTFOLIO 450
18.7.4 RECENT DEVELOPMENT 450
18.8 CANON MEDICAL INFORMATICS, INC. 451
18.8.1 COMPANY SNAPSHOT 451
18.8.2 PRODUCT PORTFOLIO 451
18.8.3 RECENT DEVELOPMENTS 451
18.9 CORELINE SOFT, CO., LTD. 452
18.9.1 COMPANY SNAPSHOT 452
18.9.2 PRODUCT PORTFOLIO 452
18.9.3 RECENT DEVELOPMENTS 452
18.10 EON 454
18.10.1 COMPANY SNAPSHOT 454
18.10.2 PRODUCT PORTFOLIO 454
18.10.3 RECENT DEVELOPMENT 454
18.11 EPIC SYSTEMS CORPORATION 455
18.11.1 COMPANY SNAPSHOT 455
18.11.2 PRODUCT PORTFOLIO 455
18.11.3 RECENT DEVELOPMENT 455
18.12 F. HOFFMANN-LA ROCHE LTD 456
18.12.1 COMPANY SNAPSHOT 456
18.12.2 REVENUE ANALYSIS 456
18.12.3 PRODUCT PORTFOLIO 457
18.12.4 RECENT DEVELOPMENTS 457
18.13 FUJIFILM HOLDINGS CORPORATION 458
18.13.1 COMPANY SNAPSHOT 458
18.13.2 REVENUE ANALYSIS 458
18.13.3 PRODUCT PORTFOLIO 459
18.13.4 RECENT DEVELOPMENTS 459
18.14 GENESYSTEM 460
18.14.1 COMPANY SNAPSHOT 460
18.14.2 PRODUCT PORTFOLIO 460
18.14.3 RECENT DEVELOPMENT 460
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
